2026-05-14 · 2026-05 / week-1

Salesforce Prices AI Fear, Not ASR Math

Salesforce Prices AI Fear, Not ASR Math

Summary: CRM last traded at $168.92 with a $160.87 billion market cap on May 14, 2026 at 4:05:26 PM UTC via the OpenAI finance tool. The tape is leaning on slower-looking guidance optics and AI anxiety even though Salesforce just finished fiscal 2026 with $41.5 billion of revenue, $15.0 billion of operating cash flow, $14.4 billion of free cash flow, and a new $25 billion accelerated share repurchase inside a $50 billion authorization. The mechanical point the market may still be underweighting is simple: management's fiscal 2027 EPS guidance explicitly excludes repurchase effects, while the ASR already delivered about 103 million shares up front and is set to settle in Q3 or Q4 of fiscal 2027. Salesforce fiscal 2026 results, February 25, 2026 Salesforce prices senior notes and enters ASR, March 11, 2026 Salesforce announces first-quarter fiscal 2027 earnings date, May 6, 2026

Opportunity Ranking

Rank Idea Discovery Lane Why It May Be Best Now Evidence Freshness Catalyst Window Asymmetry Main Reason to Reject
1 Salesforce prices AI fear, not ASR math U.S. mega-cap software / capital return / denominator reset CRM trades at $168.92 even though Salesforce produced $15.0 billion of operating cash flow, launched a $25 billion ASR, and published fiscal 2027 EPS guidance that explicitly excludes repurchase effects. Official fiscal 2026 results dated February 25, 2026, official ASR financing release dated March 11, 2026, official Q1 fiscal 2027 earnings date dated May 6, 2026, and live market snapshot checked May 14, 2026 at 4:05:26 PM UTC. Q1 fiscal 2027 results on May 27, 2026, ongoing ASR execution, and final ASR settlement in Q3 or Q4 fiscal 2027. A lower stock price can mechanically retire more shares inside a fixed-dollar ASR, while the official EPS guide still excludes that share-count help. Selected.
2 Yum China prices delivery drag, not the return stack Broader Asia / China consumer / capital return / store-growth flywheel YUMC trades at $46.27 with a $16.38 billion market cap while management remains on track to return $1.5 billion in 2026 after pre-arranging another $512 million of second-half buybacks. Official Q1 release dated April 29, 2026, official second-half repurchase announcement dated May 12, 2026, and live market snapshot checked May 14, 2026 at 4:04:53 PM UTC. H2 buybacks begin July 1, 2026 and the next quarterly print can test whether margin resilience persists. Strong capital return and growth coexist in a China-discounted stock. The disagreement is real, but China macro narrative can keep the discount open longer than the selected setup.
3 Nomura still trades as a broker, not a capital-return cycle Japan financials / below-consensus profitability / buyback NMR trades at $8.1250 after Nomura posted JPY362.1 billion of net income, 10.1% ROE, a JPY51 annual dividend, and completed a JPY60 billion buyback. Official full-year results dated April 24, 2026, official buyback completion dated April 15, 2026, and live market snapshot checked May 14, 2026 at 4:05:26 PM UTC. Dividend payment on June 1, 2026 and the next quarterly print. The earnings quality is better than the old broker discount implies. The buyback is already completed, so the closing mechanism is slower and less mechanical.
4 RELX keeps compounding, but the market already pays for it Europe / UK analytics compounder / buyback RELX trades at $30.95 after reaffirming the 2026 outlook, reporting 128.5p of adjusted EPS for 2025, and planning GBP2.25 billion of 2026 buybacks. Official 2025 results dated February 12, 2026, official trading update dated April 23, 2026, and live market snapshot checked May 14, 2026 at 4:04:53 PM UTC. Ongoing buybacks and half-year results. Quality and cash conversion remain excellent. The market already grants a premium multiple, so the disagreement is not as sharp.

Selected opportunity: Salesforce prices AI fear, not ASR math.

Why this one now: The next earnings print is only days away, the current market price is materially below the March 11 reference level implied by the ASR disclosure, and management's own fiscal 2027 EPS guide still excludes the repurchase effect that can make that lower price accretive.

What should surprise the reader: The official ASR disclosure implies roughly 129 million total shares at the March 11 reference price because the initial 103 million shares represented about 80% of the expected total. At today's $168.92, the same $25 billion would retire roughly 148 million shares before standard ASR adjustments. That is about 19 million extra shares, and the published fiscal 2027 EPS guide does not count them yet. The share-count bridge here is not commentary. It is arithmetic inference from the company's own disclosure.

The Setup

Salesforce has become an awkward stock to own.

The market sees a large software incumbent talking about agentic AI while guiding to only 7% to 8% revenue growth in fiscal 2027, with about 3 points of that growth coming from Informatica. That framing makes the story easy to reduce to one line: mature software company, financial engineering, expensive AI narrative. Salesforce fiscal 2026 results, February 25, 2026

That line misses the capital structure.

Fact: Salesforce generated $15.0 billion of operating cash flow and $14.4 billion of free cash flow in fiscal 2026, returned $14.3 billion to shareholders in the year, then added a $25 billion ASR and expanded authorization to $50 billion. Salesforce fiscal 2026 results, February 25, 2026 Salesforce prices senior notes and enters ASR, March 11, 2026

Inference: when a fixed-dollar ASR is this large, a lower stock price is not just bad sentiment. It can also mean more shares retired at settlement.

That is the disagreement. The tape looks focused on slower optics. The actual setup also contains a mechanical denominator reset that the company's official EPS guidance still excludes.

The Mispricing

The market appears to be pricing Salesforce mainly as a slower-growth software name that needs buybacks to defend the equity story.

I think that framing is too neat.

Salesforce guided fiscal 2027 non-GAAP EPS to $13.11 to $13.19 on a diluted share count of 943 million, explicitly excluding any future share repurchase activity. Q1 fiscal 2027 guidance of $3.11 to $3.13 also excludes repurchase effects and uses 937 million diluted shares. Salesforce fiscal 2026 results, February 25, 2026

That matters because Salesforce had already entered the ASR before most of fiscal 2027 even played out. If the effective average diluted share count ends up only 5% below that official full-year denominator, the same guided non-GAAP profit pool would imply roughly $13.80 to $13.88 of EPS. At a 10% lower denominator, it would imply roughly $14.57 to $14.66. Those are arithmetic inferences, not management guidance, but they show why the published guide can understate the actual EPS path when the repurchase is this large.

The non-obvious part is that the stock's weakness can help the ASR. Salesforce disclosed that the initial 103 million shares represented about 80% of the total shares expected to be repurchased based on the March 11, 2026 closing price. That implies roughly 129 million total shares at the initial reference price. At today's $168.92, the same $25 billion would buy roughly 148 million shares before standard ASR adjustments, or about 19 million more than the implied March 11 total. Again, that is inference, not a company forecast, but it is the right mechanical lens.

Price

Market Level Current Reading Source / Timestamp Why It Matters
CRM share price $168.92 OpenAI finance tool, latest trade May 14, 2026 4:05:26 PM UTC Current entry reference.
Market capitalization $160.87 billion OpenAI finance tool, same timestamp Lets us size the ASR against current equity value.
Trailing P/E 22.56x OpenAI finance tool, same timestamp The stock is not distressed, but it is no longer priced like an untouchable software premium story.
Fiscal 2026 revenue $41.5 billion Salesforce fiscal 2026 results, February 25, 2026 Confirms the business still has material scale and recurring demand.
Fiscal 2026 operating cash flow $15.0 billion Salesforce fiscal 2026 results, February 25, 2026 The buyback is funded from a real cash engine, not a slogan.
Fiscal 2026 free cash flow $14.4 billion Salesforce fiscal 2026 results, February 25, 2026 Supports continued capital return even before the new debt package.
Fiscal 2026 shareholder returns $14.3 billion Salesforce fiscal 2026 results, February 25, 2026 Shows the company was already returning capital aggressively before the ASR.
New ASR size $25.0 billion Salesforce financing and ASR release, March 11, 2026 A fixed-dollar ASR of this size makes share-count math a core part of the thesis.
Initial ASR delivery About 103 million shares Salesforce financing and ASR release, March 11, 2026 Proves the denominator reset is already underway.
Total share repurchase authorization $50.0 billion Salesforce fiscal 2026 results, February 25, 2026 The company still has substantial firepower beyond the initial ASR.
Fiscal 2027 non-GAAP EPS guide $13.11 to $13.19 Salesforce fiscal 2026 results, February 25, 2026 Official EPS frame before any repurchase effects.
Fiscal 2027 guided diluted shares 943 million Salesforce fiscal 2026 results, February 25, 2026 Management explicitly says this excludes future repurchases.
Remaining performance obligation $72.4 billion Salesforce fiscal 2026 results, February 25, 2026 Demand visibility is stronger than the market mood implies.
Current remaining performance obligation $35.1 billion Salesforce fiscal 2026 results, February 25, 2026 Gives the near-term revenue base more structure than a pure narrative stock.

Positioning

The cleanest positioning signal here is corporate, not speculative.

Salesforce itself is the bid.

The company returned $14.3 billion to shareholders in fiscal 2026, then layered on a $25 billion ASR whose initial delivery alone equaled about 103 million shares. That is not optionality. It is already a live reduction in the share count. Salesforce fiscal 2026 results, February 25, 2026 Salesforce prices senior notes and enters ASR, March 11, 2026

What I do not have in this run is a reliable live read on short interest, borrow cost, or options skew in CRM. This is not a squeeze thesis. It is a capital-return mechanics thesis with an operating business underneath it.

Catalyst

Three catalysts matter.

First, Salesforce reports Q1 fiscal 2027 results on May 27, 2026 after the market closes. That is close enough to matter now, and it is the first hard test of whether the market's AI-and-growth anxiety is too aggressive. Salesforce announces first-quarter fiscal 2027 earnings date, May 6, 2026

Second, the ASR settles in Q3 or Q4 of fiscal 2027. If the stock remains below the March 11 reference level for much of the measurement period, the final share delivery can be larger than the initial implied total. Salesforce prices senior notes and enters ASR, March 11, 2026

Third, management guided to stronger growth in the second half of fiscal 2027. If that operational bridge starts to look believable while the denominator is already shrinking, the current multiple can look too low in hindsight. Salesforce fiscal 2026 results, February 25, 2026

Payoff Map

One possible expression is long CRM common stock.

That is the cleanest wrapper because the thesis is not binary and it does not require a single quarter to do all the work. The thesis is that the market is underweighting a large, already-executing denominator reset while overfocusing on the uglier parts of the narrative.

An alternative expression is a long-dated call spread. I did not verify a live options chain during this run, so options are secondary rather than primary.

Price Target and Probability Map

Scenario Probability Target / Level Return / Payoff Time Horizon Conditions Required Evidence Quality
Top Case 30% CRM $210.00 +24.3% 6 to 12 months Q1 fiscal 2027 results show stable demand, the second-half acceleration path holds, and the market starts to price the ASR as genuine EPS accretion rather than cosmetic support. Medium
Base Case 50% CRM $190.00 +12.5% 6 to 12 months Salesforce merely executes near the official fiscal 2027 guide, the ASR keeps shrinking the denominator, and the market rerates the stock modestly as the share-count math becomes clearer. Medium / High
Bottom Case 20% CRM $145.00 -14.2% 3 to 12 months AI pressure proves more real than the bull case assumes, Informatica integration muddies execution, and the market treats the ASR as debt-funded financial engineering rather than value creation. Medium
Invalidation / Stop Condition n/a Sustained break below CRM $145.00 n/a n/a The thesis is broken if demand visibility weakens, the second-half acceleration path slips, and management can no longer defend the fiscal 2027 setup without leaning on capital structure optics. Medium

Probability-weighted expected value: approximately +10.7%, using the scenario returns above. This excludes any value from final ASR share delivery coming in better than the March 11 implied total.

Current market price / level: CRM $168.92.

Timestamp: May 14, 2026 at 4:05:26 PM UTC.

Primary instrument: CRM common stock.

Alternative expressions considered: A long-dated call spread after live options-chain liquidity is verified.

Confidence: Medium.

What Would Prove This Wrong

This thesis fails if the business weakens fast enough that share-count help stops mattering.

It is wrong if one or more of the following happens:

  • Q1 fiscal 2027 or the next quarter shows that current remaining performance obligation and cash generation are deteriorating rather than stabilizing;
  • management loses credibility on the promised second-half fiscal 2027 acceleration;
  • the market concludes the ASR was mainly a debt-funded offset to structural slowing, not a rational use of excess cash;
  • or the stock keeps falling because the AI product narrative is not translating into durable demand.

That would mean the denominator story was real, but not load-bearing enough.

Risk Audit

Strongest counterargument: The market already understands the buyback and is correctly focusing on the harder issue, which is whether Salesforce can still grow fast enough to deserve even the current multiple once AI competition and integration complexity are stripped of marketing gloss.

Most fragile assumption: That the operating business remains good enough for denominator shrink to matter. A bad software multiple can stay bad if demand credibility breaks.

What the market may already know: That the ASR is large, that the balance sheet can support it, and that lower prices can increase final share delivery. The market may simply believe this is financial engineering against a maturing revenue base.

What could make the trade lose money even if the thesis is directionally right: The buyback can be accretive and still fail to create stock upside if investors compress the multiple faster than the share count falls.

Liquidity / execution risks: Common stock liquidity is not the problem here. Narrative volatility around a mega-cap earnings print is.

Leverage risks: Salesforce funded part of the package with a large senior-notes offering. If rates stay elevated or operating momentum softens, debt-funded buybacks can be judged harshly. Salesforce prices senior notes and enters ASR, March 11, 2026

Information reliability risks: I did not verify a live options chain, live short interest, or borrow-cost data in this run. Those are non-core to the thesis.

Invalidation trigger: Later-quarter evidence that demand, cash flow, or current remaining performance obligation no longer support the second-half acceleration story, especially if the stock stays under pressure even as ASR effects should be visible.

Publish / revise / reject recommendation: Publish.

Bottom Line

Salesforce is not obviously cheap because the operating story is flawless. It is not. The opportunity is narrower and more interesting than that. The market appears to be pricing AI anxiety, slower optics, and buyback skepticism while underweighting a fixed-dollar ASR large enough to change the denominator in a way the official fiscal 2027 EPS guide still does not capture. At $168.92, the tape still looks more focused on the fear than on the math.

Best trade strategy: Long CRM common stock. Options are secondary only if a later live chain check shows liquid long-dated call spreads with acceptable pricing.

Sources